A
Amylyx Pharmaceuticals (AMLX)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Amylyx Pharmaceuticals (AMLX)
Amylyx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is developing therapies for treatment paradigm for amyotrophic lateral sclerosis (ALS), and range of neurodegenerative diseases by keeping neurons alive. The Comp... Read more
- USD2.94
- USD3.16
- USD2.94
- USD19.95
- 36.10%
- 299M
- 743.19k
- 1.42M
- 210M
- 1.58
- -83.60%
Stock News
yesterday
Constellation Brands CEO downplays worries about higher tariffs if Trump wins
CNBC
yesterday
Dow logs record high as stocks rise, Treasury yields jump after strong jobs data
MarketWatch
yesterday
East and Gulf Coast ports strike deal is not close to done: Automation still a big hurdle in ILA/USMX negotiations
CNBC
yesterday
Next steps for the Fed after strong jobs data — plus, news on health and beer stocks
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
